• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较支气管中心性肉芽肿病与肺移植后其他形式的慢性肺移植物功能障碍。

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.

机构信息

Department of Internal Medicine, Walter Reed Army Medical Center, Washington, DC 20307, USA.

出版信息

J Heart Lung Transplant. 2010 Oct;29(10):1159-64. doi: 10.1016/j.healun.2010.05.012. Epub 2010 Jun 26.

DOI:10.1016/j.healun.2010.05.012
PMID:20580267
Abstract

BACKGROUND

The radiographic presence of allograft infiltrates is atypical of bronchiolitis obliterans (BO) and inconsistent with the definition of bronchiolitis obliterans requires that restrictive processes are ruled out. The natural history of these other forms of chronic allograft dysfunction has not been well characterized. We examined the prognostic significance of radiographic and spirometric restrictive processes in comparison to BOS among lung transplant recipients.

METHODS

We performed a retrospective review of lung transplant recipients with chronic lung allograft dysfunction (CLAD) as defined by spirometry. Subgroups based on the presence or absence of persistent radiographic abnormalities were labeled as non-specific (CLAD-NS) and CLAD due to BOS (CLAD-BOS), respectively. The CLAD-BOS group was further divided into obstructive (OBOS) and restrictive (RBOS) phenotypes based on spirometry. Groups were compared with respect to survival and decline in forced expiratory volume in 1 second (FEV(1)).

RESULTS

Among 241 lung transplant recipients, 96 (40%) were identified as having CLAD, of whom 62 (65%) had CLAD-BOS and 34 (35%) CLAD-NS. No difference between groups was identified with respect to post-CLAD survival or decline in FEV(1). CLAD-BOS subgroups included 35 (56%) patients with OBOS and 27 (44%) with RBOS. There was no difference in these subgroups with respect to survival or subsequent FEV(1) decline.

CONCLUSIONS

Patients with CLAD and persistent radiographic infiltrates have a similar prognosis to BOS patients but may still represent a clinically distinct phenotype. BOS patients frequently exhibited a restrictive pattern on spirometry, which also did not offer further prognostic information, but could still represent a unique disease phenotype.

摘要

背景

同种异体移植物浸润的放射学表现是非闭塞性细支气管炎(BO)的典型表现,与闭塞性细支气管炎的定义不一致,需要排除限制过程。这些其他形式的慢性同种异体移植物功能障碍的自然史尚未得到很好的描述。我们研究了放射学和肺量计限制性过程与肺移植受者 BO 相比的预后意义。

方法

我们对慢性肺同种异体功能障碍(CLAD)进行了回顾性审查,根据肺量计进行定义。基于持续存在放射异常的存在或不存在,将亚组分别标记为非特异性(CLAD-NS)和 BO 引起的 CLAD(CLAD-BOS)。根据肺量计,CLAD-BOS 组进一步分为阻塞性(OBOS)和限制性(RBOS)表型。比较各组的生存率和 1 秒用力呼气量(FEV1)下降情况。

结果

在 241 名肺移植受者中,有 96 名(40%)被确定为患有 CLAD,其中 62 名(65%)患有 CLAD-BOS,34 名(35%)患有 CLAD-NS。CLAD 后生存率或 FEV1 下降无组间差异。CLAD-BOS 亚组包括 35 名(56%)OBOS 患者和 27 名(44%)RBOS 患者。这些亚组在生存率或随后的 FEV1 下降方面没有差异。

结论

CLAD 伴持续放射学浸润的患者与 BO 患者的预后相似,但仍可能代表一种临床独特的表型。BO 患者的肺量计检查常表现为限制性模式,这也不能提供进一步的预后信息,但仍可能代表一种独特的疾病表型。

相似文献

1
Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.比较支气管中心性肉芽肿病与肺移植后其他形式的慢性肺移植物功能障碍。
J Heart Lung Transplant. 2010 Oct;29(10):1159-64. doi: 10.1016/j.healun.2010.05.012. Epub 2010 Jun 26.
2
Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.限制性移植物综合征(RAS):一种慢性肺移植物功能障碍的新形式。
J Heart Lung Transplant. 2011 Jul;30(7):735-42. doi: 10.1016/j.healun.2011.01.712. Epub 2011 Mar 17.
3
The contribution of airway ischemia and vascular remodelling to the pathophysiology of bronchiolitis obliterans syndrome and chronic lung allograft dysfunction.气道缺血和血管重塑对闭塞性细支气管炎综合征和慢性肺移植物功能障碍的病理生理学的贡献。
Curr Opin Organ Transplant. 2010 Oct;15(5):558-62. doi: 10.1097/MOT.0b013e32833e1112.
4
Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.胃食管反流病患者在接受肺移植时行胃底折叠术后肺移植功能改善。
J Thorac Cardiovasc Surg. 2003 Mar;125(3):533-42. doi: 10.1067/mtc.2003.166.
5
Chronic lung allograft dysfunction after lung transplantation: the moving target.肺移植后慢性移植肺功能障碍:不断变化的目标。
Gen Thorac Cardiovasc Surg. 2013 Feb;61(2):67-78. doi: 10.1007/s11748-012-0167-3. Epub 2012 Nov 10.
6
Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).中性粒细胞可逆性移植肾失功(NRAD)和限制型移植肾综合征(RAS)。
Semin Respir Crit Care Med. 2013 Jun;34(3):352-60. doi: 10.1055/s-0033-1348463. Epub 2013 Jul 2.
7
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.即刻原发性肺移植功能障碍对闭塞性细支气管炎综合征的影响。
Am J Respir Crit Care Med. 2007 Mar 1;175(5):507-13. doi: 10.1164/rccm.200608-1079OC. Epub 2006 Dec 7.
8
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.肺移植慢性功能障碍命名标准化及临床分期的实用方案。国际心肺移植学会。
J Heart Lung Transplant. 1993 Sep-Oct;12(5):713-6.
9
Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?移植后基线第一秒用力呼气容积与闭塞性细支气管炎综合征的发生:一个重要的混杂因素?
J Heart Lung Transplant. 2007 Nov;26(11):1127-34. doi: 10.1016/j.healun.2007.07.041. Epub 2007 Sep 29.
10
Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.6 分钟步行试验在闭塞性细支气管炎综合征中的预后价值。
Respir Med. 2009 Dec;103(12):1816-21. doi: 10.1016/j.rmed.2009.07.011. Epub 2009 Aug 13.

引用本文的文献

1
Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients.是时候重新思考小儿患者肺或造血细胞移植后的闭塞性细支气管炎综合征了。
Cancers (Basel). 2024 Nov 4;16(21):3715. doi: 10.3390/cancers16213715.
2
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.肺或造血干细胞移植后闭塞性细支气管炎综合征:当前治疗与未来方向
ERJ Open Res. 2022 Jul 25;8(3). doi: 10.1183/23120541.00185-2022. eCollection 2022 Jul.
3
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p.
miRNAs 可能参与肺移植后闭塞性细支气管炎:miR-21-5p 的作用。
Cells. 2021 Mar 20;10(3):688. doi: 10.3390/cells10030688.
4
Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes.双肺移植后第一年最佳肺量测定的意义:与 3 年结果的关系。
Transplantation. 2020 Aug;104(8):1712-1719. doi: 10.1097/TP.0000000000003046.
5
A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.吸入性脂质体环孢素治疗肺移植后闭塞性细支气管炎综合征的单中心随机试验。
ERJ Open Res. 2019 Oct 30;5(4). doi: 10.1183/23120541.00167-2019. eCollection 2019 Oct.
6
The role of the immune system in lung transplantation: towards improved long-term results.免疫系统在肺移植中的作用:迈向更好的长期结果
J Thorac Dis. 2019 Sep;11(Suppl 14):S1721-S1731. doi: 10.21037/jtd.2019.04.25.
7
Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.供体来源的无细胞 DNA 可预测肺移植后移植物失败和死亡。
EBioMedicine. 2019 Feb;40:541-553. doi: 10.1016/j.ebiom.2018.12.029. Epub 2019 Jan 26.
8
Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.肺移植后闭塞性细支气管炎综合征无复发生存:国际心肺移植学会胸科移植登记分析。
J Heart Lung Transplant. 2019 Jan;38(1):5-16. doi: 10.1016/j.healun.2018.09.016. Epub 2018 Sep 25.
9
Chronic lung allograft dysfunction phenotypes and treatment.慢性肺移植功能障碍的表型与治疗
J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81.
10
Restrictive allograft syndrome after lung transplantation: new radiological insights.肺移植术后限制性同种异体移植综合征:新的影像学见解
Eur Radiol. 2017 Jul;27(7):2810-2817. doi: 10.1007/s00330-016-4643-5. Epub 2016 Nov 22.